ResearcherThe University of SydneyNo recent work listed

Sharleen V. Menezes

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5045186062. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2019: 1 paper

Papers 1

The metastasis suppressor, NDRG1, attenuates oncogenic TGF-β and NF-κB signaling to enhance membrane E-cadherin expression in pancreatic cancer cells. Co-author DOI 10.1093/carcin/bgy178 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Alexander Richardson · 1 shared paper, 2019 · strength 0.10
- Paper The metastasis suppressor, NDRG1, attenuates oncogenic TGF-β and NF-κB signaling to enhance membrane E-cadherin express… DOI 10.1093/carcin/bgy178 ↗
Bekesho Geleta · 1 shared paper, 2019 · strength 0.10
- Paper The metastasis suppressor, NDRG1, attenuates oncogenic TGF-β and NF-κB signaling to enhance membrane E-cadherin express… DOI 10.1093/carcin/bgy178 ↗
Žaklina Kovačević · 1 shared paper, 2019 · strength 0.10
- Paper The metastasis suppressor, NDRG1, attenuates oncogenic TGF-β and NF-κB signaling to enhance membrane E-cadherin express… DOI 10.1093/carcin/bgy178 ↗
Des Raymond Richardson · 1 shared paper, 2019 · strength 0.10
- Paper The metastasis suppressor, NDRG1, attenuates oncogenic TGF-β and NF-κB signaling to enhance membrane E-cadherin express… DOI 10.1093/carcin/bgy178 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.